Abstract:The goal to attenuate inflammation without inducing generalized immunosuppression has focused the attention on chemokines, a family of chemotactic peptides that regulate the leukocyte traffick into tissues. However, the development of drugs that block ckemokine activity may be hampered by the observation that some chemokines display pleiotropic biologic functions. For example, the chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC exhibit the ability to recruit different leukocytes subsets, the capacity to induce the proliferation of vascular pericytes as well as powerful anti-tumor effects, which are mediated by a common receptor, named CXCR3. Because of their pleiotropic biologic effects, these chemokines have been proposed as possible therapeutic targets in cancer, allograft rejection, glomerulonephritis, diabetes, multiple sclerosis, and autoimmune disorders of the thyroid. The chemokine CXCL4/PF4 shares several activities with CXCL9, CXCL10, and CXCL11, including angiostatic effects, although its specific receptor has remained unknown for a long time. Recently, we provided evidence that the different functions of CXCL9, CXCL10, and CXCL11 on distinct cell types can be at least partly explained by the interaction of these chemokines with two distinct receptors. Indeed, in addition to the classic form of CXCR3 receptor, which we have renamed as CXCR3-A, a novel CXCR3 receptor variant (CXCR3-B) was identified, that not only mediates the angiostatic activity of CXCR3 ligands, but also acts as functional receptor for CXCL4. In this review, we focus on the accumulating evidence demonstrating the pivotal role of CXCR3-binding chemokines in several human diseases. Studies based on CXCR3 targeting have shown its importance in different pathologic conditions and orally active small molecules capable of inhibiting this receptor are now being developed in order to be tested for their activity in humans.

Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review

Role of CX3CL1 in Diseases

The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System

CXCR3-binding chemokines: novel multifunctional therapeutic targets

The Potential Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Cardiovascular System, Respiratory System and Skin

CXCL3: A key player in tumor microenvironment and inflammatory diseases

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

Regulative Role of the CXCL13-CXCR5 Axis in the Tumor Microenvironment

CXCL13-CXCR5 axis：regulation in inflammatory diseases and cancer

CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer

The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease

Fractalkine/CX3CL1 in Neoplastic Processes

The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs

The Role of CXCR3 and Its Ligands in Cancer

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases

The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases

CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors

Pathological roles of the homeostatic chemokine CXCL12